PRELUDE CAPITAL MANAGEMENT, LLC - CAN-FITE BIOPHARMA LTD ownership

CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 7 filers reported holding CAN-FITE BIOPHARMA LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CAN-FITE BIOPHARMA LTD
ValueSharesWeighting
Q3 2017$2,000
+100.0%
1,200
+50.0%
0.00%
Q2 2017$1,000
-85.7%
800
-71.4%
0.00%
-100.0%
Q2 2016$7,0002,8000.00%
Other shareholders
CAN-FITE BIOPHARMA LTD shareholders Q3 2016
NameSharesValueWeighting ↓
TAYLOR ASSET MANAGEMENT INC 796,500$2,111,0000.62%
MENTA CAPITAL LLC 43,832$115,0000.01%
MORGAN STANLEY 5,400$14,0000.00%
UBS Group AG 204$1,0000.00%
IFP Advisors, Inc 1,000$3,0000.00%
Advisor Group, Inc. 4,000$10,0000.00%
GROUP ONE TRADING, L.P. 2,048$5,0000.00%
View complete list of CAN-FITE BIOPHARMA LTD shareholders